Abeona Therapeutics (ABEO) Short-Term Debt repayments (2014 - 2015)
Abeona Therapeutics (ABEO) recorded quarterly Short-Term Debt repayments of $400000.0 in Q1 2015, up 260.0% quarter-over-quarter from -$250000.0 in Q3 2014.
Abeona Therapeutics (ABEO) Short-Term Debt repayments (2014 - 2015) Analysis & Trends
Abeona Therapeutics' Short-Term Debt repayments history runs 2 years deep, the most recent figure standing at $400000.0 for Q1 2015.
- In Q1 2015, Short-Term Debt repayments changed N/A year-over-year to $400000.0; the TTM figure through Dec 2015 stood at $400000.0 (changed N/A YoY), while the FY2015 annual figure was $400000.0, changed N/A from the prior year.
- Short-Term Debt repayments was $400000.0 for Q1 2015 at Abeona Therapeutics, up from -$250000.0 in the prior quarter.
- In the past five years, Short-Term Debt repayments ranged from a high of $400000.0 in Q1 2015 to a low of -$250000.0 in Q3 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 102,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -482,347.21 |
| 10 | Abeona Therapeutics | 325.29 Mn | 157.02 Mn | 6.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | 400,000.00 |
| Mar 31, 2015 | 400,000.00 |
| Sep 30, 2014 | -250,000.00 |
| Sep 30, 2014 | -250,000.00 |